I agree that this site is using cookies. You can find further informations here.
X
Gamberi, Barbara
67  results:
Search for persons X
?
1

Anti-BCMA CAR-T cell-based therapies and bispecific antibod..:

Martino, Massimo ; Gamberi, Barbara ; Antonioli, Elisabetta...
Expert Review of Hematology.  17 (2024)  7 - p. 375-390 , 2024
Link: https://doi.org/10.1080/..
 
?
2

Belantamab mafodotin in triple‐refractory multiple myeloma ..:

Fazio, Francesca ; Petrucci, Maria Teresa ; Corvatta, Laura...
eJHaem.  5 (2024)  3 - p. 485-493 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Impact of minimal residual disease standardised assessment ..:

Zamagni, Elena ; Oliva, Stefania ; Gay, Francesca...
eClinicalMedicine.  60 (2023)  - p. 102017 , 2023
Link: https://doi.org/10.1016/..
 
?
4

P1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGI..:

D'agostino, Mattia ; Bringhen, Sara ; Giuliani, Nicola...
HemaSphere.  7 (2023)  S3 - p. e993869a , 2023
Link: https://doi.org/10.1097/..
 
?
5

Incidence, mortality, and survival of hematological maligna..:

Mangone, Lucia ; Penna, Domenico ; Marinelli, Francesco...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
6

Carfilzomib induction, consolidation, and maintenance with ..:

Mina, Roberto ; Musto, Pellegrino ; Rota-Scalabrini, Delia...
The Lancet Oncology.  24 (2023)  1 - p. 64-76 , 2023
Link: https://doi.org/10.1016/..
 
?
7

P-109 Carfilzomib-lenalidomide-dexamethasone Vs. lenalidomi..:

D'Agostino, Mattia ; Antonioli, Elisabetta ; Gamberi, Barbara...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S94-S95 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P-303 Belantamab mafodotin in patients with relapsed/refrac..:

Offidani, Massimo ; Morè, Sonia ; Cavo, Michele...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S205 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Carfilzomib combined with lenalidomide and dexamethasone (K..:

Martino, Enrica Antonia ; Conticello, Concetta ; Zamagni, Elena...
Hematological Oncology.  40 (2022)  5 - p. 1009-1019 , 2022
Link: https://doi.org/10.1002/..
 
?
10

OAB-055: Gain and amplification of 1q induce transcriptome ..:

D'Agostino, Mattia ; Belotti, Angelo ; Zamagni, Elena...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S34 , 2021
Link: https://doi.org/10.1016/..
 
?
11

P-164: Safety of lenalidomide (LEN)-based therapy vs non–LE..:

Gamberi, Barbara ; De Stefano, Valerio ; Payer, Angel Ramirez...
Clinical Lymphoma Myeloma and Leukemia.  21 (2021)  - p. S125-S126 , 2021
Link: https://doi.org/10.1016/..
 
?
12

A Noninterventional, Observational, European Post-Authoriza..:

Gamberi, Barbara ; Berthou, Christian ; Hernandez, Miguel...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  10 - p. e629-e644 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Post-Authorization Safety Study of Lenalidomide-Based vs No..:

Cavo, Michele ; De Stefano, Valerio ; Payer, Angel Ramirez...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e226-e227 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Real-World Evidence of the Use of Carfilzomib and Dexametha..:

Terpos, Evangelos ; Leleu, Xavier ; Gamberi, Barbara...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e282-e283 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Real-World Use of Carfilzomib Therapy Among Patients With E..:

Caers, Jo ; Leleu, Xavier ; Gamberi, Barbara...
Clinical Lymphoma Myeloma and Leukemia.  19 (2019)  10 - p. e281-e282 , 2019
Link: https://doi.org/10.1016/..
 
1-15